Algert Global’s Kailera Therapeutics KLRA Stock Holding History
Bought
Maintained
Sold
Other funds holding KLRA
Algert Global's KLRA Position: Q3 2026 in Review
Algert Global opened a new position in Kailera Therapeutics (KLRA) in Q3 2026: 88,260 shares worth $1.01M. The stake represents 0.01% of the portfolio and ranks #1017 among its holdings.
132 funds tracked by Wall St. Rank hold KLRA as of Q3 2026.
- Algert Global held 88,260 shares of Kailera Therapeutics worth $1.01M as of Q3 2026.
- Kailera Therapeutics was a new Algert Global position in Q3 2026.
- Kailera Therapeutics made up 0.01% of Algert Global's portfolio in Q3 2026, its #1017 holding.
- 132 funds tracked by Wall St. Rank held Kailera Therapeutics as of Q3 2026.
Based on Algert Global's 13F filing for Q3 2026, filed 17 Nov 2026.